Arterial medial calcification (AMC) is thought to share some outward similarities to skeletal mineralisation and has been associated with the transdifferentiation of vascular smooth muscle cells (VSMCs) to an osteoblast-like phenotype. ATP and UTP have previously been shown to inhibit bone mineralisation. This investigation compared the effects of extracellular nucleotides on calcification in VSMCs with those seen in osteoblasts. ATP, UTP and the ubiquitous mineralisation inhibitor, pyrophosphate (PP i ), dose dependently inhibited VSMC calcification by ≤85%. Culture of VSMCs in calcifying conditions was associated with an increase in apoptosis; treatment with ATP, UTP and PP i reduced apoptosis to levels seen in non-calcifying cells. Extracellular nucleotides had no effect on osteoblast viability. Basal alkaline phosphatase (TNAP) activity was over 100-fold higher in osteoblasts than VSMCs. ATP and UTP reduced osteoblast TNAP activity (≤50%) but stimulated VSMC TNAP activity (≤88%). The effects of extracellular nucleotides on VSMC calcification, cell viability and TNAP activity were unchanged by deletion or inhibition of the P2Y 2 receptor. Conversely, the actions of ATP/UTP on bone mineralisation and TNAP activity were attenuated in osteoblasts lacking the P2Y 2 receptor. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) hydrolyses ATP and UTP to produce PP i . In both VSMCs and osteoblasts, deletion of NPP1 blunted the inhibitory effects of extracellular nucleotides suggesting involvement of P2 receptor independent pathways. Our results show that although the overall functional effect of extracellular nucleotides on AMC and bone mineralisation is similar there are clear differences in the cellular mechanisms mediating these actions.
INTRODUCTION
Vascular calcification is a common consequence of ageing, atherosclerosis, diabetes and chronic kidney disease. It is the pathological deposition of calcium phosphate mineral, usually as hydroxyapatite, in the medial and/or intimal layer of the arteries and heart valves. Arterial medial calcification (AMC) refers to the calcification that occurs within the tunica media of blood vessels and is characterised by increased vessel stiffness and reduced blood flow (Young et al., 1993) . Traditionally, AMC was thought to be a passive process caused by high serum levels of phosphate and calcium. However, it is now accepted that it is a complex cell-mediated process that shares some similarities with the process of physiological bone formation. Specifically, AMC is thought to involve the loss of calcification inhibitors (e.g. pyrophosphate (PP i ), osteopontin, fetuin A), gain of calcification inducers (e.g. alkaline phosphatase (TNAP)) and increased apoptosis (Proudfoot et al., 2000; Zhu et al., 2012) . Whilst many cell types can contribute towards the development of AMC, vascular smooth muscle cells (VSMCs) are thought to be the major cell type involved (Narisawa et al., 2007; Zhu et al., 2011) . Within a calcifying environment (high phosphate), VSMCs can undergo a phenotypic transdifferentiation to take on characteristics usually associated with bone-forming osteoblasts (Shroff and Shanahan, 2007; Zhu et al., 2011) . ATP has long been recognized for its role in intracellular energy metabolism; however, it is also an important extracellular signalling molecule. ATP and related compounds (UTP, ADP, UDP) act via purinergic P2 receptors to regulate cell proliferation, differentiation, survival and function in many tissues (Burnstock, 2007) . The P2 receptor family is made up of seven P2X ion channels (P2X1-7) and eight P2Y G-protein coupled receptors (P2Y 1, 2, 4, 6, [11] [12] [13] [14] ) (Abbracchio and Burnstock, 1994; Burnstock and Kennedy, 1985) .
Purinergic signalling plays a number of roles in the cardiovascular system (see review (Burnstock and Ralevic, 2014) ). VSMCs express multiple P2 receptor subtypes (Wang et al., 2002) and, in recent years, several investigations have examined the role of purinergic signalling in the different forms of vascular calcification (Fish et al., 2013) . However, they provide conflicting evidence as to whether extracellular nucleotides are harmful or protective. P2Y 2 receptor mediated signalling has been shown to promote the survival of aortic valve interstitial cells and protect against aortic valve calcification (Cote et al., 2012) and arterial intimal calcification (Qian et al., 2017) . Additionally, a biochemical study showed that ATP inhibited calcium phosphate deposition in rat VSMCs (Villa-Bellosta and Sorribas, 2013) . In contrast, activation of P2YRs by Up 4 A (a non-selective P2R agonist) has been reported to enhance VSMC calcification (Schuchardt et al., 2012) .
Once released extracellular nucleotides are rapidly broken down by ecto-nucleotidases to limit their actions to cells within close proximity of the release site. PP i , a ubiquitous and potent inhibitor of calcification (Fleisch and Bisaz, 1962) , is generated when nucleotide triphosphates are hydrolysed by ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs). VSMCs express many ectonucleotidases, including NPP1, and can release ATP in a controlled manner (Prosdocimo et al., 2009; Prosdocimo et al., 2010; Villa-Bellosta et al., 2011) . Accumulating evidence now suggests that the hydrolysis of locally released ATP by NPP1 is the major source of extracellular PP i (Orriss et al., 2016; Prosdocimo et al., 2009 ). This PP i can then act locally to regulate the level of calcification. Consistent with this, NPP1 knockout mice (Enpp1 -/-) display extensive ectopic calcification in a variety of soft tissues including the aorta, kidney, cartilage, ear pinna and whisker vibrissae Johnson et al., 2003; Mackenzie et al., 2012) . Furthermore, mutations in the gene encoding NPP1 lead to the recessive condition Generalised Arterial Calcification of Infancy (GACI) which is characterised by extensive vascular calcification (Rutsch et al., 2001 ).
The regulation of bone formation by extracellular nucleotides has been widely studied often with conflicting results (see reviews (Burnstock et al., 2013; Gartland et al., 2012; Noronha-Matos and Correia-de-Sa, 2016; Orriss, 2015) ). Activation of several P2 receptors (e.g. P2Y 2 , P2X1, P2X7) has been shown to both inhibit and promote bone mineralisation (Hoebertz et al., 2002; Noronha-Matos et al., 2014; Orriss et al., 2012a; Orriss et al., 2007; Panupinthu et al., 2007; Xing et al., 2014) . We have previously reported that ATP and UTP selectively inhibit the mineralisation of the organic matrix and TNAP expression and activity (Orriss et al., 2007) . These actions are due to both P2 receptor mediated signalling and also direct hydrolysis by NPP1 to produce PP i (Orriss et al., 2012a; Orriss et al., 2013; Orriss et al., 2007) . Recently, we also demonstrated that activation of the P2Y 2 receptor exerts some of its effects on bone mineralisation indirectly by promoting the release of ATP from osteoblasts (Orriss et al., 2017) . In contrast to the potent actions of ATP and UTP, ADP and UDP do not influence bone mineralisation (Orriss et al., 2007) .
The aim of this study was to investigate the effects of extracellular nucleotides on AMC and, given the apparent similarities to bone mineralisation, to compare any functional effects to those seen in osteoblasts. Established in vitro mouse models of AMC and bone formation were used to determine the cellular mechanisms mediating these actions. Since the inhibitory effects of ATP and UTP on bone mineralisation involve both P2 receptor dependent and independent signalling we examined both pathways in parallel. background, has been previously described (Homolya et al., 1999) . Animals were bred from homozygote (P2Y 2 R -/-) and parental strain wildtype (P2Y 2 R +/+ ) breeding pairs. The generation and characterisation of mice lacking NPP1 (Enpp1 -/-), which are on a 129Sv/TerJ genetic background, has previously been described (Sali et al., 1999 
METHODS

Reagents
Aortic ring calcification assay
Aortas were isolated from P2Y 2 R +/+ or P2Y 2 R -/-mice and the adventitia layer removed. The vessels were cut into 2-3mm rings and cultured overnight in serum free αMEM. After 24 hours, the rings were transferred to calcification medium (αMEM plus 2.5mM phosphate and 2.7mM calcium chloride). Aortic rings were cultured for a further 9 days with half medium changes every 3 days.
Determination of VSMC and aortic ring calcification
Calcifying VSMCs or aortic rings were washed twice with phosphate buffered saline (PBS) and incubated with 0.6M HCl at room temperature for 24 hours. Calcium content was measured colorimetrically by stable interaction with o-cresolphthalein using a commercially available kit (Sigma-Adrich, Poole, UK) and corrected for total protein concentration using the Bradford assay. Calcium deposition was visualised by alizarin red staining of VSMC cell layers as previously described (Taylor et al., 2014) .
Osteoblast bone formation assay
Osteoblasts were isolated from the calvariae of 3-5 day old mice by trypsin/collagenase digestion as previously described Orriss et al., 2012b; Taylor et al., 2014 αMEM and cultured for 2-4 days in a humidified atmosphere of 5% CO 2 -95% air at 37C in 75 cm 2 flasks until fully confluent. Cells were sub-cultured into 6-well trays in αMEM supplemented with 2mM -glycerophosphate and 50g/ml ascorbic acid, with half medium changes every 3 days. Cells were treated with 1-100µM ATP, UTP or PP i for the duration of the culture; fresh nucleotide was added at each medium change.
To assess bone formation, experiments were terminated by fixing the cells in 2.5% glutaraldehyde for 5 minutes. Cell culture plates were imaged at 800 dpi using a flat-bed scanner (Epson Perfection 4990 Photo) and the total area of bone nodules formed was quantified by image analysis, as described previously (Orriss et al., 2012b) . Cell layers were stained with alizarin red for microscopy.
Analysis of P2 receptor gene expression by real time PCR
VSMCs were cultured in control or calcification medium for 14 days. Osteoblasts were cultured until the onset of mineralisation (14 days). RNA was extracted using RNeasy total RNA (Qiagen Ltd, Crawley, UK), according to the manufacturer's instructions. RNA was quantified and reverse transcribed as previously described (Mackenzie et al., 2014) . Levels of mRNA expression were measured using the SYBR green detection method (Roche, East Sussex, UK) as previously reported . Data are presented as (1) the fold change in expression in calcifying VSMCs relative to control cells and (2) the fold change in expression in calcifying VSMCs compared to mineralising osteoblasts. Primer sequences are shown in table 1.
Cell viability assay
VSMCs and osteoblasts were cultured for 14 days in medium supplemented with ATP, UTP, ADP, UDP or PP i (1-100µM); fresh nucleotide was added at each medium change. Cell number and viability was determined using the CytoTox 96® colorimetric cytotoxicity assay (Promega UK, Southampton UK), as described previously (Orriss et al., 2012a) . Cell supernatants were collected to determine medium LDH levels (cell viability). To establish total cellular LDH levels, cells were lysed with 1% Triton X-100 in water (lysis buffer, 15µl/ml of medium) for 1 hour. The LDH content of the supernatants and cell lysates were measured colorimetrically (490nm) as per manufacturer's instructions. A standard curve for determination of cell numbers was constructed using cells seeded at 10 2 to 10 6 /well. Cell viability (shown as percentage of dead cells) was calculated by expressing medium LDH as a percentage of the total cellular LDH.
Quantification of apoptosis by flow cytometry
VSMCs plated in 24-well trays were cultured in control or calcification medium (± treatment) for 7 days. Apoptosis was assessed via flow cytometry using an annexin V antibody conjugated to fluorescein (Life Technologies, Paisley, UK), as per manufacturer's instructions. Briefly, cells were detached using trypsin (0.25%) and resultant pellet washed in ice cold PBS. This suspension was centrifuged and resuspended in 1X annexin-binding buffer (Life Technologies, Paisley, UK). A sample of this suspension was incubated with the annexin V antibody for 15 minutes, after which, analysed using a BD FACSCanto II Flow Cytometer (Becton, Dickinson and Company, Oxford, UK). Data was processed to calculate percentage apoptosis using Flowing Software (version 2.5.1) (Turku University, Finland).
Determination of TNAP activity
VSMCs and osteoblasts VSMCs were cultured with 1-100µM ATP, UTP or PP i for 14 days; fresh nucleotide was added at each medium change. TNAP activity was measured in P2Y 2 R -/-, Enpp1 -/-or wildtype (P2Y 2 R +/+ / Enpp1 +/+ ) cell lysates using a colorimetric assay (Anaspec, CA, USA), as previously described (Orriss et al., 2012a) . TNAP activity was normalised to cell protein using the Bradford assay.
Histology
Histological analysis was performed on aortas obtained from 24-week old male P2Y 2 R +/+ or P2Y 2 R -/-mice.
Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin wax blocks. Serial sections were cut every 5µm and mounted onto slides. Before staining, the samples were deparaffinised using xylene, then rehydrated through a series of decreasing ethanol solutions and finally water. Slides were stained with haematoxylin and eosin (H&E) to examine cell morphology and alizarin red to visualise vascular calcification.
Statistical analysis
Data were analysed using GraphPad Prism 6 software (San Diego, CA). Statistical comparisons were made using one-way or two-way analysis of variance (ANOVA) with a post-hoc Bonferroni correction for multiple comparisons. Results are expressed as means ± SEM for 6 replicates and are representative of experiments performed at least three times using cells or tissues obtained from different animals.
RESULTS
P2 receptor expression is increased in calcifying VSMCs
Analysis of mRNA expression revealed that mouse VSMCs express multiple P2 receptor subtypes including all the P2X receptors and the majority of the P2Y receptors (Fig. 1A) . Expression of the P2X1, P2X2, P2X4, P2X5, P2X6 and P2Y 2 receptors was increased up to 3-fold in calcifying VSMCs compared to control VSMCs (Fig.1A) .
The relative level of P2 receptor mRNA expression between calcifying VSMCs and mineralising osteoblasts was also investigated (Fig. 1B) . Expression of P2X3 receptor mRNA was increased 2.5-fold in calcifying VSMCs. In contrast, levels of the P2X5, P2X6, P2X7, P2Y 1 , P2Y 2 and P2Y 13 receptors were reduced in calcifying VSMCs compared to mineralising osteoblasts (Fig. 1B) . All other P2 receptors was displayed a similar level of expression ATP, UTP and PP i inhibit VSMC calcification ATP (≥10µM) and UTP (≥1µM) dose dependently inhibited VSMC calcification by up to 80% ( Fig. 2A,  2B, 2F) . UTP was more potent, exerting inhibitory actions from 1µM. ADP and UDP had no effect at any of the concentrations tested (Fig. 2C, 2D, 2F ). The ubiquitous mineralisation inhibitor, PP i (≥10µM), reduced VSMC calcification up to 85% (Fig. 2E, 2F ). Representative images in Fig. 2F show the inhibitory actions of 10µM ATP, UTP or PP i on calcification in mouse VSMC cultures.
ATP, UTP and PP i increase VSMC viability and decrease apoptosis
In calcifying VSMCs, treatment with ATP, UTP and PP i (≥10µM) decreased the percentage of dead cells present by up to 75%, 60% and 80%, respectively; ADP and UDP had no effect (Fig. 3A-3E) . ATP, UTP, ADP and UDP had no effect on osteoblast cell viability (Fig. 3F-3I) . PP i at the highest dose (100µM) caused a 45% increase in the proportion of dead cells (Fig. 3J) .
Apoptosis was increased up to 2.3-fold in calcifying VSMCs compared to control VSMCs (Fig 3K-3M) . Treatment with ATP, UTP and PP i (≥10µM) decreased the level of apoptosis in calcifying cells to the level seen in control VSMCs (Fig 3K-3M ).
The effect of ATP, UTP and PP i on TNAP activity in calcifying VSMCs and osteoblasts ATP and UTP (≥1µM) increased VSMC TNAP activity by up to 88% and 50%, respectively (Fig. 4A, 4B ). PP i, (≥1µM) , which is a substrate for TNAP, dose dependently stimulated enzyme activity by up to 80% (Fig. 4C) . In contrast, ATP and UTP (≥1µM) inhibited osteoblast TNAP activity by up to 50% (Fig. 4D,  4E) . PPi had no effect on TNAP activity in osteoblasts (Fig. 3F) . It should also be noted that the basal TNAP activity of mineralising osteoblasts was at least 100-fold higher than that of a calcifying VSMCs (Fig. 4) .
The P2Y 2 receptor does not mediate the effects of ATP & UTP on VSMC calcification
Deletion of the P2Y 2 receptor had no effect on the basal level of calcification in VSMC or aortic ring cultures (Fig. 5A , 5B). The inhibitory effects of ATP and UTP on calcification were unchanged in P2Y 2 R -/-VSMCs (Fig. 5C, 5D ). The selective P2Y 2 receptor antagonist, ARC118935XX, also failed to attenuate the inhibitory effects of UTP (Fig. 5E) . Isolated aortas from 24-week old P2Y 2 R +/+ and P2Y 2 R -/-mice showed no obvious differences in structure or cell morphology (Fig. 5F ). Alizarin red staining revealed no spontaneous calcium deposition within any of the arterial layers (Fig. 5F ). Representative images shown are from the descending aorta. The effects of ATP and UTP on VSMC cell viability and TNAP activity were also unaffected by the deletion of the P2Y 2 receptor (Fig. 5G-5J ).
Reduced inhibitory effects of ATP and UTP on bone mineralisation in P2Y 2 R -/-osteoblasts ATP (≥10µM) and UTP (≥1µM) dose dependently reduced bone mineralisation in P2Y 2 R +/+ osteoblasts by up to 80% (Fig. 6A, 6B, 6E) . The overall level of mineralised bone nodule formation was up to 60% higher in P2Y 2 R -/-cells compared to P2Y 2 R +/+ . In P2Y 2 R -/-osteoblasts, the effects of ATP and UTP were only observed at 100µM making them 10-fold and 100-fold less potent at inhibiting bone mineralisation, respectively (Fig. 6A, 6B, 6E ). Representative whole well scans (unstained) and phase contrast microscopy images (alizarin red stained) of osteoblast cell layers show the reduced inhibitory effects of UTP in P2Y 2 R -/-osteoblasts. They also illustrate the increased level of bone formation in P2Y 2 R -/-cells (Fig. 6E) .
The inhibitory effects of ATP and UTP on TNAP activity are lost in P2Y 2 R -/-osteoblasts
In P2Y 2 R +/+ osteoblasts ATP (≥10µM) and UTP (≥1µM) reduce TNAP activity by up to 40%. P2Y 2 R -/-osteoblasts display basal TNAP activity levels that are up to 30% higher than wildtype cells. The inhibitory effects of ATP and UTP on TNAP activity were lost in P2Y 2 R -/-osteoblasts (Fig. 6C, 6D) .
The inhibitory effects of ATP and UTP on VSMC calcification and bone mineralisation are reduced in Enpp1 -/-mice
Since PP i mimics many of the actions of ATP and UTP we investigated whether the effects of these extracellular nucleotides involved P2 receptor independent mechanisms. In Enpp1 +/+ cells, ATP and UTP inhibit VSMC calcification from concentrations of 10µM and 1µM, respectively. In Enpp1 -/-VSMCs, ATP and UTP are 10-fold less potent only exerting inhibitory effects at 100µM and 10µM, respectively (Fig. 7A, 7B ).
Consistent with earlier studies, Enpp1
-/-osteoblasts displayed increased levels of bone mineralisation compared to Enpp1 +/+ cells (Anderson et al., 2005; Orriss et al., 2015) . The inhibitory effects of ATP and UTP on bone mineralisation were 10-fold and 100-fold less potent, respectively, in Enpp1 -/-osteoblasts (Fig. 7C, 7D ). Representative whole well scans (unstained) and phase contrast microscopy images (alizarin red stained) of osteoblast cell layers show the reduced inhibitory effects of ATP in Enpp1 -/-osteoblasts (Fig. 7E) .
NPP1 deletion does not blunt the effects of ATP and UTP on cell viability and TNAP activity
The protective effects of ATP and UTP against loss of cell viability were unchanged in cultures of Enpp1 -/-VSMCs (Fig. 8A, 8B) . Deletion of NPP1 also had no effect on the ATP/UTP-mediated increase in VSMC TNAP activity (Fig. 8C, 8D ).
DISCUSSION
This study compared the effects of extracellular nucleotides on AMC and bone mineralisation. We found that, whilst the functional effect was the same, the cellular mechanisms mediating the observed inhibitory actions of ATP and UTP differed. In VSMCs, ATP and UTP prevent calcification, at least in part, by reducing VSMC apoptosis. In contrast, ATP and UTP have no effect on osteoblast survival and instead block bone mineralisation via the inhibition of TNAP. Furthermore, the P2Y 2 receptor does not appear to mediate the actions of ATP and UTP on AMC but is involved in the effects on bone mineralisation. However, NPP1-mediated generation of PP i contributes to the inhibitory effects observed in both VSMCs and osteoblasts (see summary Fig. 9 ).
This study demonstrated, like others, that VSMCs express multiple P2X and P2Y receptor subtypes (Lewis and Evans, 2000; Wang et al., 2002) . Interestingly, the mRNA expression of several P2 receptors was upregulated in calcifying VSMCs compared to control cells. Since the expression of P2 receptors by osteoblasts is differentiation-dependent (Dixon et al., 1997; Noronha-Matos et al., 2012; Orriss et al., 2006) , this could reflect the changes in the VSMC phenotype which occur during the development of AMC.
Consistent with earlier work that described protective effects of extracellular nucleotides on aortic valve calcification (Cote et al., 2012) and VSMC calcification (Villa-Bellosta and Sorribas, 2013), we also found that both ATP and UTP were inhibitory. Whereas, ADP and UDP were without effect. UTP, which was more potent than ATP, only activates the P2Y 2 and P2Y 4 receptor subtypes. Given the involvement of the P2Y 2 receptor in inhibiting bone mineralisation (Fig. 6) (Hoebertz et al., 2002; Orriss et al., 2007) , aortic valve calcification and intimal calcification (Cote et al., 2012; Qian et al., 2017) , the P2Y 2 receptor appeared to be a strong candidate for mediating the effects in VSMCs. However, the effects of ATP and UTP on VSMC calcification were not lost in P2Y 2 R -/-cells or blocked by a selective P2Y 2 receptor antagonist. Furthermore, P2Y 2 R -/-VSMCs and aortic rings displayed no differences in the basal level of calcification in vitro and isolated aortas from 24-week old animals also showed no signs of AMC. It should be noted that aged animals were not studied here and so it is possible that the condition develops in older P2Y 2 R -/-mice. Taken together, these data suggest that ATP and UTP are not acting via the P2Y 2 receptor to regulate AMC.
Our findings contrast to previous work which has implicated the P2Y 2 receptor in the effects of nucleotides on valve calcification (Cote et al., 2012) and arterial intimal calcification (Qian et al., 2017) . There are a number of potential explanations for these observed differences. First, the lack of involvement of the P2Y 2 receptor in aortic VSMCs could represent variation in the cellular mechanisms that underpin these different forms of pathological vascular calcification. Second, it could be due to differences in the experimental models used since each investigation has utilised distinct in vitro and in vivo methods to study the different forms of vascular calcification. Finally, we observed that P2Y 2 receptor mRNA expression was significantly lower in calcifying VSMCs than mineralising osteoblasts. This suggests that P2Y 2 receptor-mediated signalling could be of lesser importance in the regulation of calcification processes in aortic VSMCs.
Extracellular nucleotides are rapidly hydrolysed by ecto-nucleotidases, meaning that the parent molecule is only present in the culture medium for a very short period of time. Particularly important is the breakdown of ATP and UTP by NPP1 to produce the key local inhibitor of mineralisation, PP i . Since the effects of PP i on VSMC calcification mimicked those of ATP and UTP, we used Enpp1 -/-cells to determine the involvement of P2 receptor-independent mechanisms. The effects of ATP and UTP were blunted in Enpp1 -/-VSMCs and osteoblasts suggesting that NPP1-mediated hydrolysis to produce PP i does contribute to the observed inhibitory actions in both cell types. This is consistent with earlier work that examined the role of ATP-derived PP i in VSMC calcification (Prosdocimo et al., 2009; Prosdocimo et al., 2010) and bone formation Orriss et al., 2007) . However, since the effects were not completely attenuated it suggests that other mechanisms are also involved. In osteoblasts, this is likely to involve activation of the P2 receptors implicated in the regulation of bone mineralisation by ATP and/or UTP, such as the P2Y 2 , P2X1 and P2X7 receptors (Hoebertz et al., 2002; Orriss et al., 2012a; Orriss et al., 2007) . In VSMCs, the other mechanisms leading the functional effects are less clear. Although unlikely to be mediated by the P2Y 2 receptor, involvement of other P2 receptor subtypes (e.g. the P2Y 4 receptor) is probable, and presents an area for future study. Furthermore, since VSMCs have been shown to also express functional NPP3 (Prosdocimo et al., 2009 ), a role for other ectonucleotidases cannot be discounted.
Increased VSMC apoptosis has been implicated in the development of vascular calcification (Proudfoot et al., 2000) . In this study we found that, at the concentrations which inhibited calcification, ATP, UTP and PP i prevented the increase in apoptosis usually seen in calcifying VSMC cultures. The effect of extracellular nucleotides on cell viability was unchanged in Enpp1 -/-VSMCs. This suggests that, although PP i itself appears to exert protective actions, ATP and UTP are working directly to promote VSMC survival in calcifying conditions. Apoptosis is thought to promote calcification because the VSMCderived apoptotic bodies can act as a nucleation site for hydroxyapatite crystal formation (Proudfoot et al., 2000) . Thus, the inhibitory effects of extracellular nucleotides (and PP i ) on AMC could be mediated, at least in part, by their ability to reduce apoptosis. The overall result being that there are less apoptotic bodies on which calcification can be initiated. In contrast, extracellular nucleotides have no effect on osteoblast viability and so the inhibitory effects on bone mineralisation are clearly not mediated via alterations in apoptosis.
These differential effects of extracellular nucleotides on cell survival may also illustrate the differences between physiological bone mineralisation and pathological AMC. Bone mineralisation is not associated with increased levels of osteoblast apoptosis and instead matrix vesicles are the primary nucleation site for hydroxyapatite formation (Anderson et al., 1975) . The initiation of AMC appears more heterogeneous with multiple factors acting as nucleation sites for calcification including apoptotic bodies and mineralisation-competent vesicles (Kapustin and Shanahan, 2012; Proudfoot et al., 2000) .
TNAP is a crucial enzyme in bone mineralisation, with deficiencies leading to hypophosphatasia, a condition characterised by hypomineralisation and rickets (Caswell et al., 1991) . Increased TNAP expression and activity has also been associated with AMC (Narisawa et al., 2007; Sheen et al., 2015) . We have previously shown that ATP and UTP reduce TNAP expression and activity in osteoblasts (Orriss et al., 2007) . Here, we demonstrate that these inhibitory actions involve P2Y 2 receptor activation since the effects on TNAP activity were lost in P2Y 2 R -/-osteoblasts. In contrast, at concentrations where calcification is inhibited by up to 80%, ATP and UTP stimulated VSMC TNAP activity. The reasons for this counterintuitive increase are unclear but since PP i , and to a lesser extent ATP and UTP, are hydrolysed by TNAP the higher substrate levels could lead to alterations in enzyme kinetics. It is important to note that, even when stimulated, the TNAP activity of calcifying VSMCs was at least 100-fold lower than that of mineralising osteoblasts in vitro. Taken together, our observations suggest that whilst reduced TNAP activity contributes to the inhibition of bone mineralisation by ATP and UTP, alterations in TNAP activity are unlikely to mediate the functional effects of nucleotides on VSMC calcification. Instead the effects on VSMC apoptosis appear to predominate. Furthermore, although TNAP is essential for bone mineralisation its role in AMC appears more complex.
It should be noted that, whilst cell culture conditions were very similar, they were not identical because the use of different phosphate sources was required; VSMCs and osteoblasts were grown in 2mM sodium phosphate or 2mM β-glycerophosphate, respectively. VSMCs did not calcify in 2mM β-glycerophosphate probably because they lack sufficient TNAP to generate the free phosphate needed for calcification. Whilst it is unlikely that this small variation in culture conditions caused the different cellular responses to extracellular nucleotides, contributory effects cannot be fully discounted.
It is widely accepted that the development of AMC shares similarities to physiological bone formation. Whilst the role of NPP1 was similar in both VSMCs and osteoblasts, this study demonstrated that there are also clear differences in the cellular mechanisms mediating the inhibitory effects of extracellular nucleotides. This suggests that some of the underlying processes leading to AMC and bone mineralisation are not the same. It is these differences which need to be fully understood in order to identify a drug target or therapeutic agent that can prevent or regress AMC without exerting negative actions on the skeleton. The inhibitory effects of (A) ATP and (B) UTP were 10-fold and 100-fold less potent, respectively, in P2Y 2 R -/-osteoblasts; mineralised bone nodule formation was 60% higher in P2Y 2 R -/-osteoblasts. The inhibitory actions of (C) ATP and (D) UTP on TNAP activity were lost in P2Y 2 R -/-osteoblasts. Basal ATP and UTP inhibit both AMC and bone mineralisation but there are some differences in the mechanisms mediating these actions. In VSMCs (top), ATP and UTP act via P2 receptors to decrease apoptosis and, as a consequence, calcification. In osteoblasts (OBs, bottom panel), ATP and UTP act via the P2Y 2 receptor to inhibit alkaline phosphatase (TNAP) activity. However, for both cell types hydrolysis of ATP and UTP to produce PP i by NPP1 also contributes to the inhibitory effects observed. 
